Charles Schwab Investment Management Inc Care Dx, Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 526,028 shares of CDNA stock, worth $8.01 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
526,028
Previous 496,803
5.88%
Holding current value
$8.01 Million
Previous $8.82 Million
16.56%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding CDNA
# of Institutions
213Shares Held
55.5MCall Options Held
85KPut Options Held
33.1K-
Black Rock Inc. New York, NY5.29MShares$80.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.91MShares$74.7 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.54MShares$38.7 Million0.01% of portfolio
-
Bamco Inc New York, NY2.44MShares$37.1 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$33.2 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $814M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...